Shuichi Okamoto, Takashi Tokunaga, Sonoko Shimoji, Akane Kunitomi, Yasuhiko Miyata, Hiroatsu Iida, Hirokazu Nagai (National Hospital Organization Nagoya Medical Center)

Norihito Inoue¹, Masahiro Yokoyama¹, Anna Nishihara¹, Hirofumi Yamauchi^1,4, Yoshiharu Kusano¹, Yuko Mishima¹, Noriko Nishimura¹, Shoko Marshall⁴, Naoko Tsuyama³, Kengo Takeuchi², Kiyohiko Hatake⁵, Yasuhito Terui¹ (1.Hematology and Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Pathology Project for Molecular Targets Project, Cancer Institute, Tokyo, Japan, 3.Pathology, Cancer Institute, Tokyo, Japan, 4.Medical Oncology, Cancer Institute Hospital of JFCR, Tokyo, Japan, 5.Hematology, International University of Health and Welfare, School of Medicine.)

Kento Umino^1,2, Shin-Ichiro Fujiwara¹, Daisuke Minakata¹, Chihiro Yamamoto¹, Akiko Meguro², Tomohiro Matsuyama³, Kazuya Sato¹, Ken Ohmine¹, Tohru Izumi², Kazuo Muroi¹, Yoshinobu Kanda¹ (1.Jichi Medical University, Tochigi, Japan, 2.Department of Hematology, Tochigi Cancer Center, Tochigi, Japan, 3.Department of Hematology, Haga Red Cross Hospital, Tochigi, Japan)

Yusuke Kanemasa¹, Tatsu Shimoyama¹, Yuki Sasaki², Tsukasa Yamaguchi¹, Chikako Funasaka¹, Tsunekazu Hishima³, Yasushi Omuro¹ (1.Medical Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 2.Clinical Research Support, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Pathology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan)

Hiroyuki Kobayashi (Nasu Red Cross Hospital, division of hematology,Tochigi, Japan)

Hikaru Tsukasaki, Keiichi Kinoshita, Shin Imamura, Kenichi Kamiya (Department of hematology, Fukui Red Cross Hospital, Fukui, Japan)